Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas W G van Rhijn

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
European Urology|September 15, 2014
Word of wisdom. Re: prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology reviewElisabeth E Fransen van de Putte, Bas W G van Rhijn
The Journal of Urology|March 25, 2025
Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage of 2 Grading SystemsAshish M Kamat, Bas W G van Rhijn, Theodorus Van der Kwast
Nature Reviews. Urology|July 2, 2014
Landmarks in non-muscle-invasive bladder cancerLaura S Mertens, Yann Neuzillet, Simon Horenblas, et al.
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesTom J N Hermans, Laura S Mertens, Bas W G van Rhijn
Urology|January 29, 2014
Reply: To PMID 24468513Laura S Mertens, Maria Carmen Mir, Bas W G van Rhijn, et al.
European Urology|July 29, 2019
Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder CancerCharlotte S Voskuilen, Michiel S van der Heijden, Bas W G van Rhijn
Current Opinion in Urology|June 2, 2023
Recent developments in perioperative combination therapy in muscle-invasive bladder cancerJan-Jaap J Mellema, Bas W G van Rhijn, Michiel S van der Heijden
Expert Review of Anticancer Therapy|November 30, 2010
Optimal timing of radical cystectomy in T1 high-grade bladder cancerPeter J Boström, Sultan Alkhateeb, Bas W G van Rhijn, et al.
European Urology|March 28, 2015
Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the BladderBas W G van Rhijn, Mark A Behrendt, Kees Hendricksen, et al.
European Urology|June 1, 2005
Urine markers for bladder cancer surveillance: a systematic reviewBas W G van Rhijn, Henk G van der Poel, Theo H van der Kwast
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
European Urology|September 15, 2014
Word of wisdom. Re: prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology reviewElisabeth E Fransen van de Putte, Bas W G van Rhijn
The Journal of Urology|March 25, 2025
Hybrid 3-Tier Bladder Cancer Grade: The Mutually Beneficial Marriage of 2 Grading SystemsAshish M Kamat, Bas W G van Rhijn, Theodorus Van der Kwast
Nature Reviews. Urology|July 2, 2014
Landmarks in non-muscle-invasive bladder cancerLaura S Mertens, Yann Neuzillet, Simon Horenblas, et al.
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesTom J N Hermans, Laura S Mertens, Bas W G van Rhijn
Urology|January 29, 2014
Reply: To PMID 24468513Laura S Mertens, Maria Carmen Mir, Bas W G van Rhijn, et al.
European Urology|July 29, 2019
Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder CancerCharlotte S Voskuilen, Michiel S van der Heijden, Bas W G van Rhijn
Current Opinion in Urology|June 2, 2023
Recent developments in perioperative combination therapy in muscle-invasive bladder cancerJan-Jaap J Mellema, Bas W G van Rhijn, Michiel S van der Heijden
Expert Review of Anticancer Therapy|November 30, 2010
Optimal timing of radical cystectomy in T1 high-grade bladder cancerPeter J Boström, Sultan Alkhateeb, Bas W G van Rhijn, et al.
European Urology|March 28, 2015
Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the BladderBas W G van Rhijn, Mark A Behrendt, Kees Hendricksen, et al.
European Urology|June 1, 2005
Urine markers for bladder cancer surveillance: a systematic reviewBas W G van Rhijn, Henk G van der Poel, Theo H van der Kwast
Pageof 22